Adhering to the service tenet of "Integrity, Innovation, Harmony, and Win-win", We have established a complete one-stop procurement and comprehensive solution service system.
API Nepafenac powder cas 78281-72-8 is a non-steroidal anti-inflammatory drug indicated for the prevention and treatment of inflammation and pain associated with cataract surgery.
API Nepafenac powder cas 78281-72-8
Product introduction：
Cas: 78281-72-8
Other names: AL 6515, AHR 9434, Nevanac
MF: C15H14N2O2
Molecular Weight: 254.28
Appearance: Yellow or light yellow crystalline powder
Loss on drying: ≤ 1.0%
Assay: 99.0%
Description: API Nepafenac powder cas 78281-72-8 is a non-steroidal anti-inflammatory drug indicated for the prevention and treatment of inflammation and pain associated with cataract surgery. After administration, nepafenac penetrates the cornea and is rapidly metabolised to amfenac by hydrolases. Nepafenac and amfenac work by potently inhibiting COX-1 and COX-2 enzymes.
Application: This medication is used to relieve eye pain, irritation, and redness following cataract eye surgery. API Nepafenac powder cas 78281-72-8 belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances (prostaglandins) in your body that cause pain and swelling.
Other chemical names: AHR 9434, AL 6515, Nevanac, 2-(2-amino-3-benzoyl-phenyl)acetamide
Certificate of Analysis
|
Items |
Standards |
Results |
|
Appearance |
Yellow or light yellow crystalline powder |
Conforms |
|
Loss on drying |
≤0.5% |
0.20% |
|
Related substances |
Individual impurity: NMT 0.5% |
0.05% |
| Total impurities: NMT 1.0% |
0.08% |
|
|
Sulphated ash |
≤0.1% |
0.06% |
|
Heavy metals |
≤20ppm |
Conforms |
|
Assay |
98.5%~101.5% |
99.3% |
Sign up for our latest news & articles. We won’t give you spam mails.
Note: We do not publish your email
